Dissecting Human Gene Functions Regulating Islet Development With Targeted Gene Transduction

• Published in: Diabetes (New York, N.Y.) Vol. 64; no. 8; pp. 3037 - 3049
• Main Authors: Pauerstein, Philip T, Sugiyama, Takuya, Stanley, Susan E, McLean, Graeme W, Wang, Jing, Martín, Martín G, Kim, Seung K
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.08.2015
• Subjects: Animals; Basic Helix-Loop-Helix Transcription Factors - genetics; Basic Helix-Loop-Helix Transcription Factors - metabolism; Cell Differentiation - genetics; Cell Lineage - genetics; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Gene Expression Regulation, Developmental; Genes; Genetics/Genomes/Proteomics/Metabolomics; Genotype & phenotype; Humans; Islets of Langerhans - cytology; Islets of Langerhans - embryology; Islets of Langerhans - metabolism; Mice; Mice, Knockout; Mutation; Nerve Tissue Proteins - genetics; Nerve Tissue Proteins - metabolism; Pancreas; Regulatory Factor X Transcription Factors; Signal transduction; Transcription factors; Transcription Factors - genetics; Transcription Factors - metabolism
• ISSN: 0012-1797; 1939-327X
• DOI: 10.2337/db15-0042

During pancreas development, endocrine precursors and their progeny differentiate, migrate, and cluster to form nascent islets. The transcription factor Neurogenin 3 (Neurog3) is required for islet development in mice, but its role in these dynamic morphogenetic steps has been inferred from fixed tissues. Moreover, little is known about the molecular genetic functions of NEUROG3 in human islet development. We developed methods for gene transduction by viral microinjection in the epithelium of cultured Neurog3-null mutant fetal pancreas, permitting genetic complementation in a developmentally relevant context. In addition, we developed methods for quantitative assessment of live-cell phenotypes in single developing islet cells. Delivery of wild-type NEUROG3 rescued islet differentiation, morphogenesis, and live cell deformation, whereas the patient-derived NEUROG3(R107S) allele partially restored indicators of islet development. NEUROG3(P39X), a previously unreported patient allele, failed to restore islet differentiation or morphogenesis and was indistinguishable from negative controls, suggesting that it is a null mutation. Our systems also permitted genetic suppression analysis and revealed that targets of NEUROG3, including NEUROD1 and RFX6, can partially restore islet development in Neurog3-null mutant mouse pancreata. Thus, advances described here permitted unprecedented assessment of gene functions in regulating crucial dynamic aspects of islet development in the fetal pancreas.